Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure-Reference-Cited by-同舟云学术

Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure

Published:2023-04 Issue:3 Volume:20 Page:896-907
ISSN:1878-7479
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Yue Jipeng,Khan Reas S.,Duong Thu T.,Dine Kimberly E.,Cui Qi N.,O'Neill Nuala,Aravand Puya,Liu Tehui,Chaqour Brahim,Shindler Kenneth S.,Ross Ahmara G.^ORCID

Funder

National Institute of Health

Harold Amos Faculty Development Award

Research to Prevent Blindness

Foundation Fighting Blindness

Paul MacKall and Evanina Bell MacKall Trust

Center for Advanced Retinal and Ocular Therapeutics, Perelman School of Medicine, University of Pennsylvania

F. M. Kirby Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-023-01364-6.pdf

Reference34 articles.

1. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;Br J Ophthalmol,2006

2. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study;GBD 2019 Blindness and Vision Impairment Collaborators;Lancet Glob Health,2021

3. Managing glaucoma in developing countries;Leite;Arq Bras Oftalmol,2011

4. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa;Rotchford;Ophthalmology,2003

5. Targets of neuroprotection in glaucoma;He;J Ocul Pharmacol Ther,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of SNCG and NEFH Promoter–Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma;Translational Vision Science & Technology;2024-08-23

2. AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma;International Journal of Molecular Sciences;2024-08-15

3. Comparison of Brn3a and RBPMS Labeling to Assess Retinal Ganglion Cell Loss During Aging and in a Model of Optic Neuropathy;Investigative Opthalmology & Visual Science;2024-04-08

4. AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes;Gene Therapy;2024-01-10

5. Genes as drugs for glaucoma: latest advances;Current Opinion in Ophthalmology;2023-12-21